Emerging adverse event signals of new analgesic suzetrigine: a disproportionality analysis of the FAERS database - PubMed
6 hours ago
- #Disproportionality Analysis
- #Suzetrigine
- #Adverse Events
- Suzetrigine is a new non-opioid analgesic that avoids respiratory depression and dependence seen with opioids.
- Its safety profile is still being established; this study used disproportionality analysis on FAERS data.
- Four adverse event signals identified: paresthesia, burning sensations, swollen tongue, and abnormal dreams.
- Paresthesia had the highest probability of being a real side effect based on statistical indices.
- Overall, suzetrigine shows a reassuring safety profile with few new side effects after one year of widespread use.